These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The clinical pharmacology of loop diuretics in the pediatric patient. Eades SK; Christensen ML Pediatr Nephrol; 1998 Sep; 12(7):603-16. PubMed ID: 9761364 [TBL] [Abstract][Full Text] [Related]
8. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states. Sagar S; Sharma BK; Sharma PL; Wahi PL Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378 [TBL] [Abstract][Full Text] [Related]
9. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)]. Fries D; Beroniade V; Coy JL; Delavelle F Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349 [TBL] [Abstract][Full Text] [Related]
10. Long-term bumetanide treatment of renal edema. Comparison with furosemide. Whelton A J Clin Pharmacol; 1981; 21(11):591-8. PubMed ID: 7040493 [TBL] [Abstract][Full Text] [Related]
11. Clinical use of diuretics in congestive heart failure. Hutcheon D; Vincent ME; Sandhu RS J Clin Pharmacol; 1981; 21(11):668-72. PubMed ID: 7338577 [TBL] [Abstract][Full Text] [Related]
12. Bumetanide in congestive heart failure. Kourouklis C; Christensen O; Augoustakis D Curr Med Res Opin; 1976; 4(6):422-31. PubMed ID: 793779 [TBL] [Abstract][Full Text] [Related]
13. [Bumetanide--a new potent diuretic for oral and intravenous use]. Johansson BW Lakartidningen; 1975 Sep; 72(37):3413-6. PubMed ID: 1099368 [No Abstract] [Full Text] [Related]
14. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Clissold SP; Brogden RN Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305 [TBL] [Abstract][Full Text] [Related]
15. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. Konecke LL J Clin Pharmacol; 1981; 21(11):688-90. PubMed ID: 7040496 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide. Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411 [TBL] [Abstract][Full Text] [Related]
17. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. Ng TM; Konopka E; Hyderi AF; Hshieh S; Tsuji Y; Kim BJ; Han SY; Phan DH; Jeng AI; Lou M; Elkayam U J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300 [TBL] [Abstract][Full Text] [Related]
18. [Loop-diuretics anno 1992. Mechanisms of effect and current therapeutic principles]. Berg KJ Tidsskr Nor Laegeforen; 1992 Feb; 112(5):656-8. PubMed ID: 1557735 [TBL] [Abstract][Full Text] [Related]
19. Disposition and response to bumetanide and furosemide. Brater DC Am J Cardiol; 1986 Jan; 57(2):20A-25A. PubMed ID: 3511654 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of bumetanide and furosemide in long-term treatment of edema due to congestive heart failure. Dixon DW; Barwolf-Gohlke C; Gunnar RM J Clin Pharmacol; 1981; 21(11):680-7. PubMed ID: 7338579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]